Randall N. Hyer

Chief Executive Officer Merlin Biotech

Seminars

Tuesday 22nd July 2025
Tumor Suppression With mRNA-Encoded Ubiquitin-Specific Protease 6 (USP6) in Broad Pediatric & Adult Cancer Indications
12:30 pm

Download the Full Event Guide to see session details.

Wednesday 23rd July 2025
Panel Discussion: Examining the Pathway of mRNA Cancer Vaccines From Preclinical to Clinical Development to Get Effective Therapies to Cancer Patients Faster
1:35 pm

Download the Full Event Guide to see session details.

Randall Hyer